Screener
Collegium Pharmaceutical, Inc. COLL Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:34 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053851
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Commitments and contingencies (refer to Note 17) | ||
| Shareholders’ equity: | ||
| Preferred stock, $0.001 par value; authorized shares - 5,000,000 | — | — |
| Common stock, $0.001 par value; authorized shares - 100,000,000; 41,527,032 issued and 32,498,310 outstanding shares as of June 30, 2026 and 40,736,330 issued and 31,707,608 outstanding shares as of December 31, 2025 | 41 | 41 |
| Additional paid-in capital | 636,062 | 624,954 |
| Treasury stock, at cost; 9,028,722 shares as of June 30, 2026 and December 31, 2025 | (222,510) | (222,510) |
| Accumulated other comprehensive income | — | 319 |
| Accumulated deficit | (101,684) | (101,129) |
Item 1. Condensed Consolidated Financial Statements (Unaudited).
FAQ
- What is Collegium Pharmaceutical, Inc.'s common stock, par value (in dollars per share)?
- Collegium Pharmaceutical, Inc. (COLL) reported common stock, par value (in dollars per share) of $0 in Q2 2026.
- What does common stock, par value (in dollars per share) mean?
- Common stock, par value (in dollars per share)
Ask your AI about Collegium Pharmaceutical, Inc.'s common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude